LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC announces a class action lawsuit has been filed against ERBA Diagnostics, Inc. (“ERBA” or the “Company”) (NYSE MKT: ERB). Investors who purchased or otherwise acquired shares between April 14, 2014 and November 23, 2015, inclusive (the “Class Period”), are encouraged to contact the Firm prior to the February 1, 2016 lead plaintiff motion deadline.
To participate in this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at email@example.com.
According to the complaint, the Company issued materially false and misleading statements to investors and/or failed to disclose that: (1) ERBA’s accounting of intercompany transactions among its subsidiaries, including its consolidated financial statements, were improper and had an impact on reported assets and liabilities; (2) ERBA lacked adequate controls over financial reporting; (3) ERBA’s financial statements during the Class Period were materially false and misleading; and (4) as a result, the Company’s statements about ERBA’s business, operations and prospects were materially false and misleading.
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.